Your browser doesn't support javascript.
loading
From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway.
Zhan, Mei-Miao; Hu, Xue-Qin; Liu, Xiu-Xiu; Ruan, Ban-Feng; Xu, Jun; Liao, Chenzhong.
Affiliation
  • Zhan MM; School of Medical Engineering, Hefei University of Technology, Hefei 230009, China.
  • Hu XQ; School of Medical Engineering, Hefei University of Technology, Hefei 230009, China.
  • Liu XX; School of Medical Engineering, Hefei University of Technology, Hefei 230009, China.
  • Ruan BF; School of Medical Engineering, Hefei University of Technology, Hefei 230009, China.
  • Xu J; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
  • Liao C; School of Medical Engineering, Hefei University of Technology, Hefei 230009, China. Electronic address: czliao@hfut.edu.cn.
Drug Discov Today ; 21(6): 1027-36, 2016 06.
Article in En | MEDLINE | ID: mdl-27094104
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Receptor Limits: Animals / Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Receptor Limits: Animals / Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: China Country of publication: Reino Unido